Therefore, our results suggest a downregulation of the glycan structures, derived from B3GALT4, ST3GAL2 and/or SLC35A1 genes, with ageing, a feature so far only described in neurodegenerative diseases [72]. This evidence concerns the gene SLC35A1 and neurodegenerative disease.